ArticlePharmacology research & perspectives2019

Target validation: Weak selectivity of LY341495 for mGluR2 over mGluR4 makes glutamate a less selective agonist.

Tyler W McCullock et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.